Bianco, Assunta and Maggi, Loredana and Marturano, Monia and Presicce, Giorgia and Mirabella, Massimiliano (2021) Urinary Dysfunction Improvement after Treatment with Sativex® in a Multiple Sclerosis Patien. European Journal of Case Reports in Internal Medicine, 8 (Sup 2). pp. 25-27. ISSN 2284-2594
|
Text
urinary_disfunction.pdf Download (255kB) | Preview |
Abstract
Nabiximols has been approved to treat multiple sclerosis-related spasticity symptoms; it also improves symptoms such as pain, urinary dysfunction and sleep disturbance. We report the case of a 43-year-old patient with multiple sclerosis who started add-on treatment with nabiximols for moderate spasticity (self-reported discomfort by the Numeric Rating Scale 6/10); she experienced a remarkable improvement in pre-existing urinary dysfunction. Nabiximols enables treatment of more spasticity-related symptoms, reducing the need for symptomatic medications and avoiding the unnecessary adverse effects produced by polytherapy.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Multiple sclerosis, spasticity, urinary dysfunction, nabiximols, Sativex® |
Subjects: | 600 Tecnologia - Scienze applicate 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
Depositing User: | Marina Spanti |
Date Deposited: | 19 Jan 2022 17:10 |
Last Modified: | 19 Jan 2022 17:10 |
URI: | http://eprints.bice.rm.cnr.it/id/eprint/21477 |
Actions (login required)
View Item |